SHARE

As per Fior Markets latest report, the estimates show that the global angioplasty balloons market would see the growth from USD 2,131.34 Million in 2017 to USD 2,834.53 Million by 2025 with a CAGR of 3.61% during the forecast period from 2018-2025. North America, which accounted for the largest market share, is now projected to witness significant growth over the next decade.  Factors such as rising cases of cardiovascular and lifestyle-associated disorders and high adoption rate of novel technologies are contributing to the market growth. They are estimated to lead the growth of angioplasty balloons market in this region.

Global Angioplasty Balloons Market by Product Type (Normal Balloon Catheter, Drug-Eluting Balloons, Cutting Balloon Catheter, Scoring Balloon Catheter), Material, Application, End User, Region” and Global Forecast 2018-2025.

DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/362193/request-sample

Key players functioning in the industry include Boston Scientific Corporation, Medtronic PLC, Abbott Inc., Johnson & Johnson, C.R. Bard Inc, Spectranetics, Cardinal Health Inc., BIOTRONIK SE & Co.KG, Cook Medical Inc, ENDOCOR GmbH, B. Braun Melsungen AG, Terumo Corporation, Koninklijke Philips, Covidien, Cordis Corporation, Thomas Medical, Inc.among others. Considering partnerships or collaborations and product and technological developments, the top players would augment the market during the forecast years. Medtronic PLC launched its drug-coated balloon IN.PACT Admiral in 2014 as a treatment option for peripheral artery disease. In 2018, Cagent vascular expanded its serranator family of percutaneous transluminal angioplasty (PTA) serration balloon catheters. This is calculated to expand balloon catheters product range.

The type segment is sub-segmented into normal balloon catheter, drug-eluting balloons, cutting balloon catheter, scoring balloon catheter. Drug-eluting balloons (DEBs) is projected to become the fastest-growing type segment and achieve the highest CAGR of 5.86% in the forecast period. The key factors driving the demand of the segment includes new product launch, advantages over the standard balloon and low cost as compared to conventional stents. The material segment is classified into non-compliant material and semi-compliant material. Application segment contains peripheral and coronary. The end user segment is divided into ambulatory surgery centers (ascs), hospitals and catheterization laboratories. In 2017, ambulatory surgery centers held the largest share of 36.28% and it is responsible for the huge demand for the treatments in these settings.

ACCESS FULL REPORT:https://www.fiormarkets.com/report/global-angioplasty-balloons-market-by-product-type-normal-362193.html

Over high-cost stent placements, surgeons mostly prefer angioplasty because it’s a minimally invasive procedure which is driving the market. Besides, the adoption of advanced technologies is fuelling the growth of the market. The growth restraining factors include reimbursement issues and alternatives choices like bypass surgery, the risk of infection. Technological advancements, growing incidences of peripheral vascular diseases and increasing R&D are expected to boost the market in the coming years.

Customization of the Report:
This report can be customized to meet the client’s requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.